查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056332

果凍市場報告：按產品、原料、應用、最終用戶和地區分類（2026-2034 年）

Biosurgery Market Report by Product, Source, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球果凍果凍規模達156億美元。展望未來，IMARC Group預測，2026年至2034年間，該市場將以5.54%的複合年成長率成長，到2034年達到258億美元。北美憑藉其先進的醫療基礎設施、大量的研發投入以及眾多領先企業推動的創新和業務拓展，已成為全球最大的生物外科區域市場。此外，手術數量的增加、醫療設備技術的進步以及對複雜手術中有效傷口管理日益成長的需求，都有助於改善全球患者的手術效果和縮短康復時間。

由於醫療技術的進步和醫療需求的不斷變化，果凍市場正經歷顯著的變革。隨著果凍技術日趨成熟與複雜，醫療領域與學術機構的合作也日益加強。學術和研究機構在新型生物材料的研究、新手術技術的建立以及透過臨床試驗檢驗新產品的有效性方面發揮核心作用。這種合作使製造商和科學家能夠攜手合作，更快地將新產品推向市場，從而加速創新果凍解決方案的發展。此外，學術機構在培養未來外科醫師了解生物外科的益處和應用方面也發揮著積極作用。隨著越來越多的醫療專業人員接受生物來源產品的培訓，這些產品在臨床實務中的應用和接受度也不斷提高。合作研究有助於我們更深入了解複雜的生物機制，而獲得的寶貴見解正被用於開發更完善的生物外科解決方案，造福不同的病患小組。

生物外科市場的發展趨勢：

生物外科產品的技術進步

技術發展正顯著推動果凍市場的快速成長。生物材料的不斷改進提高了止血劑、黏合劑和組織工程產品的效率。各公司正致力於開發更有效率、生物相容性更好、永續的外科產品。例如，促進創傷治療和增強組織再生的生物活性材料的進步正在革新這一領域。此外，3D列印技術的發展促進了個人化植入和手術器械的製造，從而實現了更有效率、更個人化的手術流程。這些進步不僅改善了手術效果，也使生物外科產品更容易取得且價格更實惠。隨著新技術的湧現，生物外科解決方案的範圍不斷擴大，滿足了更廣泛的手術需求，並促進了各個醫學專科的患者照護水平的提高。 3D Systems宣布，該公司與瑞士巴塞爾大學醫院合作，利用其專有的即時檢測（PoC）積層製造解決方案，生產了全球首個符合醫療設備法規（MDR）的3D列印PEEK臉部植入。弗洛里安·蒂林格教授和內哈·夏爾馬博士，以及一支生物醫學工程師團隊，利用3D Systems公司的技術和製造專長，高效地設計並製造了一種客製化設備，以滿足患者的特定需求。該植入已於2025年3月18日在該院成功用於手術。

對微創手術的需求日益成長

對微創手術日益成長的需求是市場成長的主要驅動力之一。隨著醫療專業人員和患者尋求最大限度地縮短恢復時間和降低傳統開放性手術的風險，越來越多的微創手術正在進行。這些手術幾乎總是切口更小、對周圍組織的損傷更少、出血更少，從而縮短恢復時間並減少併發症。止血鉗和黏合劑等生物外科產品在這些手術中發揮重要作用，它們有助於確保精確的組織封閉和止血。外科醫師也會在微創手術中使用生物材料來加速創傷治療並降低感染風險。隨著微創手術在各個專科領域的推廣，對支持這些手術的生物外科解決方案的需求不斷成長，進一步推動了市場成長。該機構預測，2033年，全球微創手術市場規模將達949億美元。

全球老化

全球人口老化正在顯著推動生物外科市場的成長。世界衛生組織（WHO）發布的2025年報導預測，到2030年，60歲以上人口將達到14億人。隨著年齡成長，人們往往會患上各種需要手術的疾病，包括關節重建、心血管手術和整形外科手術。老年患者的再生能力通常較弱，更容易在手術期間和術後出現併發症。為了應對這些挑戰，生物外科器械，例如組織工程移植物、創傷治療產品和黏合劑，正被廣泛應用，以加速康復、降低感染風險並最佳化組織再生。此外，老年患者通常患有需要持續醫療照護的慢性疾病，這增加了對先進生物外科解決方案的需求。因此，隨著醫療保健系統擴大採用先進技術來改善手術效果並縮短老年患者的康復時間，全球人口老化正在推動市場成長。

果凍市場成長的促進因素：

醫療保健成本不斷上漲，以及人們對先進外科手術解決方案的興趣日益濃厚

隨著全球醫療成本的不斷攀升，先進外科解決方案（例如生物外科產品）的優勢日益凸顯。如今，醫護人員和病患都更意識到生物工程外科產品相較於傳統合成產品所帶來的益處。這些好處包括縮短癒合時間、減少併發症以及提高生物相容性，而這些對於最大程度地提升手術效果至關重要。醫療系統，尤其是在已開發國家，正大力投資這些先進解決方案，以提高醫療品質並控制與長期康復和併發症相關的成本。隨著越來越多的醫護人員採用先進的外科技術，生物活性敷料、組織移植片和可生物分解縫線等生物外科器械在各種手術中正變得不可或缺。

慢性病和外科手術數量增加

糖尿病、心血管疾病和肥胖等慢性疾病的日益普遍正在推動市場成長。大多數慢性疾病最終都會導致需要手術治療的併發症，例如糖尿病潰瘍、血管手術和關節重建。隨著這些疾病盛行率的上升，對能夠加速康復和減少併發症的新型外科產品的需求也隨之成長。創傷護理生物溶液、組織修復溶液和止血劑等生物外科產品正擴大應用於外科手術中，以改善慢性疾病患者的治療效果。例如，生物移植和敷料在糖尿病患者癒合緩慢的複雜慢性傷口中發揮著至關重要的作用。隨著全球慢性疾病負擔的加重，對生物外科產品的需求日益廣泛，這些產品已成為現代外科手術不可或缺的一部分。

擴大新興市場的醫療保健服務覆蓋範圍

新興經濟體醫療保健服務的普及正在推動市場成長。開發中國家醫療基礎設施的改善和先進醫療技術的普及不斷刺激對生物外科產品的需求。這些國家整形外科、循環系統和創傷治療手術數量的增加，推動了生物外科產品的使用。隨著人們更容易獲得高品質的醫療保健服務，能夠改善手術效果的生物外科產品的應用也在不斷擴展。此外，許多政府和醫療系統正在投資旨在提高手術品質和降低併發症發生率的項目，這進一步刺激了對生物來源外科解決方案的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球果凍市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 骨移植替代物
  • 軟組織附件
  • 止血劑
  • 外科密封劑和黏合劑
  • 黏附屏障
  • 釘線加固

第7章 市場區隔：依來源

  • 天然和生物製藥
  • 合成產品

第8章 市場區隔：依應用領域分類

  • 整形外科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 婦科手術
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi SA
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
Product Code: SR112026A4522

The global biosurgery market size reached USD 15.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.54% during 2026-2034. North America was the largest regional market for biosurgery owing to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Moreover, the increasing surgical procedures, technological advancements in medical devices, and growing demand for effective wound management in complex surgeries is enhancing surgical outcomes and recovery times for patients across the globe.

The market for biosurgery is undergoing immense changes with the advancement of medical technologies and evolving healthcare requirements. The growing promise and complexity of biosurgical technologies are stimulating more interaction between the medical sector and academic centers. Academic institutions and research institutes are taking center stage in investigating new biologic materials, creating new surgical methods, and testing the efficacy of new products through clinical trials. This cooperative setting is developing the swift growth of innovative biosurgical solutions, as manufacturers and scientists collaborate to advance new products to market more quickly. In addition, academic centers play an active role in training future surgeons about the advantages and applications of biosurgery. With increasing numbers of healthcare professionals being trained in the handling of biologically derived products, the uptake and acceptance of these products in clinical practice is also growing. Collaborative research endeavors are also refining the understanding of complicated biological mechanisms, and useful insights are being utilized in developing improved biosurgical solutions that can benefit various patient groups.

Biosurgery Market Trends:

Technological Progress in Biosurgical Products

Technological developments are contributing tremendously to the faster growth of the biosurgery market. Ongoing improvements in biologic materials are increasing the efficiency of products like hemostats, adhesives, and tissue-engineered products. Companies are targeting more efficient, biocompatible, and sustainable surgical products. For instance, advances in bioactive materials that promote faster wound healing and enhance tissue regeneration are revolutionizing the space. In addition, development in 3D printing technology is facilitating the production of personalized implants and surgical instruments, making way for more efficient and tailor-made surgical interventions. These developments not only enhance surgical performance but also make biosurgical products more accessible and affordable. With new technologies coming onto the scene, the scope of biosurgical solutions is increasing, treating more types of surgical requirements and facilitating improved patient care across a variety of medical specialties. 3D Systems revealed that, in partnership with University Hospital Basel (Switzerland), the Company's exclusive point-of-care additive manufacturing solution is utilized to create the world's first 3D-printed PEEK facial implant compliant with Medical Device Regulation (MDR). Prof. Florian Thieringer and Dr. Neha Sharma, along with their team of biomedical engineers, effectively created and produced a tailored device to meet a patient's specific requirement utilizing 3D Systems technology and manufacturing knowledge. This implant was utilized in a successful operation finished at the hospital on March 18, 2025.

Increased Demand for Minimally Invasive Procedures

The heightened need for minimally invasive procedures is one of the fundamental growth drivers in the market. As medical practitioners and patients aim to minimize the recovery time and risks involved with conventional open surgeries, more minimally invasive procedures are being performed. These surgeries, in most cases, entail smaller cuts, less trauma to the tissues around them, and less blood loss, resulting in shorter recovery periods and fewer complications. Biosurgical items, including hemostats and biologic adhesives, are part of these procedures as they facilitate better tissue sealing and bleeding control with accuracy. Surgeons are also employing biologic materials for better wound healing and the prevention of chances of infection in minimally invasive procedures. With the trend toward minimally invasive procedures in all specialties, the need for biosurgical solutions that enable these procedures is increasing, further fueling the market growth. The publisher predicts that the global minimally invasive surgery market is anticipated to reach USD 94.9 Billion by 2033.

Aging Global Population

The aging world population is playing a huge role in driving the biosurgery market. As per an article published by the World Health Organization (WHO) in 2025, the number of people aged 60 and above is anticipated to increase to 1.4 billion by 2030. As individuals grow older, they tend to develop a variety of ailments that call for surgeries, including joint replacements, cardiovascular procedures, and orthopedic procedures. Elderly patients generally possess slower recovery mechanisms and are more prone to surgical and post-surgical complications. These issues are being dealt with by biosurgical devices like tissue-engineered grafts, wound healing products, and biologic adhesives that are facilitating quicker recovery, minimizing the risk of infection, and optimizing tissue regeneration. Second, as older patients have more chronic diseases that necessitate continuous medical care, the need for sophisticated biosurgical solutions is also on the increase. The elderly population worldwide is therefore fueling the market growth since healthcare systems are increasingly embracing advanced technologies to enhance surgical outcomes and reduce recovery periods for older patients.

Biosurgery Market Growth Drivers:

Increasing Healthcare Costs and Sensitivity to Advanced Surgical Solutions

Health care spending is rising globally, and advanced surgical solutions, such as biosurgical products, are increasingly recognized as having advantages. Both healthcare professionals and patients are more aware today about the benefits that biologically engineered surgical products provide over conventional synthetic ones. These include lower healing times, fewer complications, and better biocompatibility, which are important for maximizing surgical outcomes. Healthcare systems, especially those in the developed world, are now investing heavily in such sophisticated solutions to enhance care quality and contain the costs of long-term recovery and complications. With more medical specialists adopting sophisticated surgical methods, biosurgical devices like bioactive dressings, tissue grafts, and biodegradable sutures are becoming part and parcel of a variety of procedures.

Increasing Incidence of Chronic Diseases and Surgical Surgeries

The increasing incidence of chronic diseases, including diabetes, cardiovascular disease, and obesity, is propelling the market growth. Most chronic diseases result in conditions that are likely to be treated with surgery, like diabetic ulcers, vascular surgeries, and joint replacements. As these conditions become more prevalent, the demand for novel surgical products that enhance faster recovery and lower complications is increasing. Biosurgical products like biologic solutions for wound care, tissue repair solutions, and hemostatics are finding growing use in surgeries to provide improved patient outcomes for chronic patients. For instance, biologic grafts and dressings play a crucial role in healing chronic, complicated wounds that are slow to heal in diabetic patients. With the growing global burden of chronic disease, the need for biosurgical products is spreading wide, making these products integral parts of contemporary surgical procedures.

Expanding Healthcare Access in Emerging Markets

Increased access to healthcare in emerging economies is bolstering the market growth. The developing world's improvement in healthcare infrastructure and access to sophisticated medical technology continues to catalyze the demand for biosurgical products. These nations are observing increased rates of surgeries in orthopedic, cardiovascular, and trauma care segments, which are driving the use of biosurgery products. As the populations become increasingly accessible to quality healthcare, biosurgical products with improved surgical outcomes are finding increased applications. Furthermore, numerous governments and healthcare systems are investing in projects aimed at enhancing surgical care and minimizing the incidence of medical complications, thus creating additional demand for biologically derived surgical solutions.

Biosurgery Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product, source, application and end user.

Breakup by Product:

  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Bone-graft substitutes account for the majority of the market share

Bone-graft substitutes are crucial alternatives to bone grafting. These stand-ins play a critical role in many surgical operations, supporting bone regeneration and repair in orthopedics, trauma, spine surgery, and dentistry applications. They are intended to minimize the risk of donor site morbidity and infection by promoting bone development and replacing conventional autografts, which require removing bone from the patient's own body. Furthermore, the expansion is driven by the increasing frequency of bone and joint problems, the need for less intrusive operations, and developments in biomaterial technology. The growth of this market segment is also fueled by the creation of novel synthetic and composite grafts with improved osteoconductive and osteoinductive qualities. For instance, on 23 May 2023, Royal Biologics, Inc., a company focused on advanced cellular and autologous technologies for improved surgical outcomes, unveiled BIO-REIGN 3D. This innovative bone graft substitute is the first to use a natural hyper-crosslinked carbohydrate polymer. It is designed to enhance bone grafting procedures, and this proprietary technology is introduced alongside Royal Biologics' licensing agreement for Molecular Matrix's patented Osteo-P BGS technology.

Breakup by Source:

  • Natural/Biologics Products
  • Synthetic Products

Natural/biologics products hold the largest share of the industry

According to the biosurgery market overview, natural/biologics represent the largest segment due to their effective healing properties and biocompatibility. These products, derived from substances that are naturally present in the human body or other biological sources, include fibrin sealants, collagen-based matrices, and chitosan-based solutions. Additionally, natural/biologics product's ability to mimic natural physiological processes significantly reduces the risk of rejection and adverse reactions, making them highly preferred in surgical procedures. Moreover, market dominance is further supported by advancements in biotechnology that enhance the safety and efficacy of these materials. Consequently, the increasing demand for minimally invasive surgeries, coupled with the growing prevalence of chronic diseases requiring complex surgeries, continues to drive the growth of natural/biologics products in the market.

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

Neurological surgery represents the leading market segment

Neurological surgeries are complex and require critical precision. Additionally, biosurgery products, such as sealants, hemostatic agents, and adhesion barriers, are extensively used in neurological procedures to manage bleeding, seal tissues, and reduce post-operative complications. Moreover, the rising prevalence of neurological disorders, such as brain tumors, epilepsy, and Parkinson's disease, coupled with advancements in neurosurgical techniques are escalating the demand in this segment. Besides, the widespread adoption of minimally invasive (MI) surgeries, which require highly effective biosurgical solutions to enhance patient outcomes is further driving the biosurgery market growth. This trend is supported by technological innovations in biosurgery products, aimed at improving surgical outcomes and reducing recovery times.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospital exhibits a clear dominance in the market

Hospitals offer a wide array of surgical procedures that frequently utilize biosurgical products. These products, which include hemostatic agents, surgical sealants, and adhesives, are integral in managing intraoperative and postoperative bleeding and promoting tissue healing. Additionally, hospitals' capacity to handle high patient volumes and conduct complex surgeries increases biosurgery demand. Additionally, the constant advancements in surgical techniques and the increasing preference for minimally invasive surgeries further amplify the utilization of biosurgical solutions in hospital settings.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biosurgery market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for biosurgery.

North America is the leading region due to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Additionally, the increasing prevalence of chronic diseases and the growing elderly population in North America contribute to a higher demand for biosurgical products. According to the biosurgery market forecast, these factors, combined with favorable government policies and a strong trend toward minimally invasive surgeries, will continue to strengthen North America's leading position in the global biosurgery market.

Competitive Landscape:

  • The biosurgery market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.
  • At present, biosurgery market players are actively enhancing market growth through a combination of strategic collaborations, innovative product launches, and expansions into new geographical markets. These companies invest heavily in research and development (R&D) to introduce advanced products that meet the increasing demands of minimally invasive surgeries and improved wound care. Additionally, market players are focusing on obtaining regulatory approvals across different regions, which helps in expanding their global footprint and accessing new markets. These strategies collectively contribute to the robust growth and resilience of the biosurgery market. For instance, in 2023, AROA Biosurgery Ltd. revealed the release of a new retrospective pilot case series that explores the use of Myriad Matrix and Myriad Morcells in the surgical treatment of contaminated volumetric soft tissue defects. It reviewed 13 complex traumatic wounds in 10 patients at a single facility. The study reported an average time of 23.4+-9.2 days for achieving soft tissue coverage and fill, with a median of one product application and no complications among participants. Moreover, the research focused on injuries from motor vehicle accidents, abdominal dehiscence after hernia repair, Fournier's Gangrene, compartment syndrome, and pressure injuries at a US Level 1 trauma center. It found that the Myriad products facilitated effective soft tissue formation with no reported complications, reinforcing the utility of AROA ECM products in trauma care.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biosurgery market?
  • What is the impact of each driver, restraint, and opportunity on the global biosurgery market?
  • What are the key regional markets?
  • Which countries represent the most attractive biosurgery market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biosurgery market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the biosurgery market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biosurgery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biosurgery market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biosurgery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2025
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: China: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: India: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: France: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2025
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million USD), 2026-2034
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players